Form 4 for PEPG PepGen Inc.
Accepted 2022-05-10 00:00:00 ET · period of report 2022-05-10 · accession 0000899243-22-017488 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-10 | 2022-05-10 | PEPG | Oxford Science Enterprises plc | 10% | C - Cnv Deriv | $0.00 | +3.76M | 2.33M | New | $0 |
| DM | 2022-05-10 | 2022-05-10 | PEPG | Oxford Science Enterprises plc | 10% | C - Cnv Deriv | $0.00 | -3.82M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | C | A | 1,262,986 | $0.00 | 1,381,846 | D | — | — | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |
| 2 | Common | Common Stock | 2022-05-10 | C | A | 1,547,713 | $0.00 | 3,875,418 | D | — | — | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |
| 3 | Common | Common Stock | 2022-05-10 | C | A | 945,859 | $0.00 | 2,327,705 | D | — | — | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |
| 4 | Derivative | Series A-2 Preferred stock | 2022-05-10 | C | D | 962,884 | $0.00 | 0 | D | — · — to — | 945,859 Common Stock | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |
| 5 | Derivative | Series B Preferred stock | 2022-05-10 | C | D | 1,575,572 | $0.00 | 0 | D | — · — to — | 1,547,713 Common Stock | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |
| 6 | Derivative | Series A-1 Preferred stock | 2022-05-10 | C | D | 1,285,720 | $0.00 | 0 | D | — · — to — | 1,262,986 Common Stock | (F1) On May 10, 2022, each share of Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on a 1.018-for-1 basis without payment of further consideration upon closing of the initial public offering of the Issuer's Common Stock. The shares of Preferred Stock had no expiration date. |